BTG3 and systemic lupus erythematosus: Most of the patients with LP are ANA positive and either precede or follow the systemic manifestations of lupus.4 Current evidence suggests use of hydroxychloroquine; followed by methotrexate (MTX), azathioprine and mycophenolate in recalcitrant cases.5